Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J R, Sainsbury"'
Autor:
Anthony Howell, Robert E. Coleman, E. Kumpulainen, W Jaeger, P.E. Jonssen, J R Sainsbury, Roger W. Blamey, John F.R. Robertson, J. Winstanley, C. Selby, Emilio Bombardieri, J.J. Syzmendera, Henrik Grönberg
Publikováno v:
European Journal of Cancer. 35:47-53
An established biochemical index for monitoring therapy in patients with metastatic breast cancer was tested prospectively in a multicentre study. The index uses two serum tumour markers—carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3
Autor:
Victoria Hiley, Mitch Dowsett, H. Thorpe, Timothy J. Perren, J R Sainsbury, Sarah Brown, A Nejim, Julia Brown
Publikováno v:
British Journal of Cancer
The effect of breast cancer surgery timing during the menstrual cycle on prognosis remains controversial. We conducted a multicentre prospective study to establish whether timing of interventions influences prognosis. We report 3-year overall and dis
Autor:
J F, Robertson, W, Jaeger, J J, Syzmendera, C, Selby, R, Coleman, A, Howell, J, Winstanley, P E, Jonssen, E, Bombardieri, J R, Sainsbury, H, Gronberg, E, Kumpulainen, R W, Blamey
Publikováno v:
European journal of cancer (Oxford, England : 1990). 35(1)
An established biochemical index for monitoring therapy in patients with metastatic breast cancer was tested prospectively in a multicentre study. The index uses two serum tumour markers--carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (
Autor:
K S, Eyres, J R, Sainsbury
Publikováno v:
The British journal of clinical practice. 44(8)
Two cases of large bowel involvement from metastatic breast cancer are presented. The literature is reviewed and the clinical implications are discussed.
Autor:
J. R. Sainsbury
Publikováno v:
Royal Australian Planning Institute Journal. 1:10-16
Autor:
A L, Harris, B M, Cantwell, J R, Sainsbury, G, Needham, R G, Evans, P J, Dawes, R, Wilson, J, Farndon
Publikováno v:
Breast cancer research and treatment.
Aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily was used to treat 76 postmenopausal women with advanced breast cancer. There were 4 CR, 17 PR (objective response rate 28%). Highest response was in soft tissue. CNS toxicity w
Autor:
C, Wright, B, Angus, S, Nicholson, J R, Sainsbury, J, Cairns, W J, Gullick, P, Kelly, A L, Harris, C H, Horne
Publikováno v:
Cancer research. 49(8)
Sections of formalin-fixed, paraffin-embedded tissue from 185 primary breast carcinomas were stained immunohistochemically using a polyclonal antibody against the c-erbB-2 oncoprotein. Positive staining, which is known to correlate with gene amplific
Autor:
J R, Sainsbury, J, Wagget
Publikováno v:
The British journal of clinical practice. 38(2)
Publikováno v:
Breast cancer research and treatment.
The endocrine effects of aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily were assessed in 45 postmenopausal women with advanced breast cancer. Oestrone and oestradiol levels were suppressed by 60% within 2 weeks and suppress
Publikováno v:
Bristol Medico-Chirurgical Journal